Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective

INTRODUCTION: Atopic dermatitis (AD), a predominantly type 2 inflammatory skin disease, affects approximately 2–5% of adults, with a high burden of disease. In moderate-to-severe AD, lesions can be extensive and pruritus intense with patients experiencing skin pain, sleep and mental health disturban...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bruin-Weller, Marjolein, Merola, Joseph F., Hong, Chih-ho, Baldrich, Esther Serra, Ettler, Karel, Sierka, Debra, Delevry, Dimittri, Chen, Zhen, Rossi, Ana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611144/
https://www.ncbi.nlm.nih.gov/pubmed/34767181
http://dx.doi.org/10.1007/s13555-021-00621-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611144/
https://www.ncbi.nlm.nih.gov/pubmed/34767181
http://dx.doi.org/10.1007/s13555-021-00621-w

Ejemplares similares